Trial intelligence / Profile preview

Temozolomide for elderly patients with poor-performance supratentorial glioblastoma

2006-005549-12Phase 2Active

Sponsor: Assistance publique - Hôpitaux de Paris
Start: Mar 2007
Modality: Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2, open-label, single-arm trial of temozolomide in glioblastoma (GBM), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Overall survival. Started Mar 2007; status: active.

Drugs

temozolomide

Conditions

glioblastoma (GBM)

Beyond the preview

Go deeper on 2006-005549-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005549-12.